iNtRON Biotechnology, Inc. (KOSDAQ:048530)
5,480.00
-970.00 (-15.04%)
Mar 9, 2026, 3:30 PM KST
41.60% (1Y)
| Market Cap | 167.99B |
| Revenue (ttm) | 5.56B |
| Net Income (ttm) | -6.29B |
| Shares Out | 30.65M |
| EPS (ttm) | -197.47 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 100.00 (1.55%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 1,265,544 |
| Average Volume | 2,724,326 |
| Open | 5,850.00 |
| Previous Close | 6,450.00 |
| Day's Range | 5,300.00 - 5,980.00 |
| 52-Week Range | 2,895.00 - 7,010.00 |
| Beta | 0.30 |
| RSI | 62.05 |
| Earnings Date | Mar 11, 2026 |